Article
Generation of an isogenic human induced pluripotent stem cell line harbouring a CLDN11 mutation associated with hypomyelinating leukodystrophy.
Stem cell research - 1 Jun 2026
Gjervan Sophia C, Sequiera Glen Lester, Feng Jia, Ozgoren Oguz, Van Belois Katherine, Kersey Braden, Ross Colin, Klein Geltink Ramon, Stockler Sylvia, Pouladi Mahmoud A
Abstract excerpt
Stoploss mutations in CLDN11 were first described as the cause of hypomyelinating leukodystrophy 22 (HLD22). Since then, a novel variant in CLDN11, namely NM_005602.5:c.564del; p.(Arg189ValfsTer31), has been identified in patients with hypomyelinating leukodystrophy resembling HLD22. To better characterize the functional significance of this novel variant and to study the mechanisms underlying CLDN11-related...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
